INTERNATIONAL PATENT: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. FILES APPLICATION FOR "EARLY ADVERSE EVENT (AE) DERIVED MARKERS PREDICT CLINICAL OUTCOMES OF A TREATMENT REGIMEN"

GENEVA, March 26 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (12902 Magnolia DriveTampa, Florida 33612-9497) filed a patent application (PCT/US2024/046973) for "EARLY ADVERSE EVENT (AE) DERIVED MARKERS PREDICT CLINICAL OUTCOMES OF A TREATMENT REGIMEN" on Sep 16, 2024. With publication no. WO/2025/059686, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Dung-Tsa (5077 Southampton CircleTampa, Florida 33647), BEG, Amer (16326 Heathrow DriveTampa, Florida 33647), GRAY, Jhanelle (32426 Talimena LoopWesle...